Jacques Gillart

Suggest Changes
Learn More
The aim of this study was to assess the pharmacokinetics, biodistribution and metabolism of [18F]EF3, a labelled 2-nitroimidazole hypoxia marker, in ten patients with head and neck cancer. [18F]EF3(More)
  • 1